The World Health Organization (WHO) said on Saturday it would be discontinuing the use of hydroxychloroquine and combination HIV drug lopinavir/ritonavir in hospitalized patients with COVID-19 after they failed to reduce mortality rates. The WHO said its decision does not affect other studies where those drugs are used for non-hospitalized patients or as a prophylaxis.
- Canada reports 219 new coronavirus infections as two-thirds of overall cases recover
- WHO discontinuing trials of hydroxychloroquine, HIV drugs on COVID-19 patients